nach oben

Journal of Cancer Research and Clinical Oncology

Erschienen in:

04.01.2023 | Research

Suppression of exosomal hsa_circ_0001005 eliminates the Vemurafenib resistance of melanoma

verfasst von: Xicheng Wang, Qiong Cheng

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 9/2023

Einloggen, um Zugang zu erhalten

Abstract

Objectives

More and more evidences show that circular RNAs (circRNAs) can be used as miRNA sponge to regulate the drug resistance of malignancies, including melanoma. However, how exosomal circRNAs participate in the therapeutic resistance of melanoma remains ambiguous.

Methods

Vemurafenib-resistant A375 cells were cultured and then the circRNA profile of exosomes from the parental A375 and A375-resistant cells were sequenced. Transmission electron microscopy (TEM), exogenous nanoparticle tracking analysis (NTA) and Western Blot assays were leveraged to confirm the successful collection of exosomes from A375 and A375R cells. Another five published RNA-seq data and microRNA-seq data, and seven miRNA databases were collected to construct a competing endogenous RNA (ceRNA) network. Comprehensive bioinformatic analysis was adopted to identify key molecules related to the drug resistance, including multiscale embedded gene co-expression network analysis (MEGENA). Then, qRT-PCR, cell viability and colony formation were used to estimate the function of hub circRNAs. The role of has_circ_0001005 in vivo was verified via xenograft assay. The Tumor online Prognostic analyses Platform (ToPP) was leveraged to develop the has_circ_0001005-related prognostic models for melanoma patients based on TCGA data.

Results

Compared with parental cells, hsa_circ_0001005 expression was significantly increased in resistant cells and their exosomes. The elevated level of hsa_circ_0001005 was related to the poor clinical prognosis of melanoma patients. Hsa_circ_0001005 found in melanoma was mainly secreted by drug-resistant cells as exosomes. Exosomal hsa_circ_0001005 activated multiple canonical pathways related to drug resistance through sponging four miRNAs, thus suppressing the drug sensitivity of melanoma. Knocking down hsa_circ_0001005 in vitro, we found that the inhibition of hsa_circ_0001005 could hinder the clone formation of melanoma. Further in vivo animal experiments suggested that suppression of hsa_circ_0001005 can increase the sensitivity to Vemurafenib of melanoma cells. Finally, we also constructed the functional regulatory ceRNA network and prognostic risk models for hsa_circ_0001005, and further survival analysis reveals that the regulatory network and prognostic risk models obviously affected the prognosis of melanoma patients.

Conclusions

This study confirmed that the level of hsa_circ_0001005 in exosomes is the key factor affecting drug resistance of melanoma, which provides a new potential therapeutic target for melanoma patients.

Nur mit Berechtigung zugänglich

Bandyopadhyay S, Mitra R (2009) TargetMiner: microRNA target prediction with systematic identification of tissue-specific negative examples. Bioinformatics 25(20):2625–2631PubMed

Brighton HE, Angus SP, Bo T et al (2018) New mechanisms of resistance to MEK inhibitors in melanoma revealed by intravital imaging. Cancer Res 78(2):542–557PubMed

Caporali S, Amaro A, Levati L et al (2019) miR-126-3p down-regulation contributes to dabrafenib acquired resistance in melanoma by up-regulating ADAM9 and VEGF-A. J Exp Clin Cancer Res 38(1):272PubMedPubMedCentral

Chen Y, Wang X (2020) miRDB: an online database for prediction of functional microRNA targets. Nucleic Acids Res 48(D1):D127–D131PubMed

Chen G, Huang AC, Zhang W et al (2018) Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response. Nature 560(7718):382–386PubMedPubMedCentral

Chou CH, Shrestha S, Yang CD et al (2018) miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions. Nucleic Acids Res 46(D1):D296–D302PubMed

Davis J, Wayman M (2022) Encorafenib and binimetinib combination therapy in metastatic melanoma. J Adv Pract Oncol 13(4):450–455PubMedPubMedCentral

Du WW, Yang W, Liu E et al (2016) Foxo3 circular RNA retards cell cycle progression via forming ternary complexes with p21 and CDK2. Nucleic Acids Res 44(6):2846–2858PubMedPubMedCentral

Felicetti F, Errico MC, Bottero L et al (2008) The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms. Cancer Res 68(8):2745–2754PubMed

Felicetti F, De Feo A, Coscia C et al (2016) Exosome-mediated transfer of miR-222 is sufficient to increase tumor malignancy in melanoma. J Transl Med 14:56PubMedPubMedCentral

Glazar P, Papavasileiou P, Rajewsky N (2014) circBase: a database for circular RNAs. RNA 20(11):1666–1670PubMedPubMedCentral

Gonzalez M, de Mayo Las Casas C, Oramas J et al (2021) Intermittent BRAF inhibition in advanced BRAF mutated melanoma results of a phase II randomized trial. Nat Commun 12(1):7008–10

Hood JL, San RS, Wickline SA (2011) Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis. Cancer Res 71(11):3792–3801PubMed

Huser L, Sachindra S, Granados K et al (2018) SOX2-mediated upregulation of CD24 promotes adaptive resistance toward targeted therapy in melanoma. Int J Cancer 143(12):3131–3142PubMed

Iero M, Valenti R, Huber V et al (2008) Tumour-released exosomes and their implications in cancer immunity. Cell Death Differ 15(1):80–88PubMed

Krzywinski M, Schein J, Birol I et al (2009) Circos: an information aesthetic for comparative genomics. Genome Res 19(9):1639–1645PubMedPubMedCentral

Lewis BP, Shih IH, Jones-Rhoades MW et al (2003) Prediction of mammalian microRNA targets. Cell 115(7):787–798PubMed

Li JH, Liu S, Zhou H et al (2014) starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res 42(Database issue):92–97

Lima LG, Chammas R, Monteiro RQ et al (2009) Tumor-derived microvesicles modulate the establishment of metastatic melanoma in a phosphatidylserine-dependent manner. Cancer Lett 283(2):168–175PubMed

Liu CX, Chen LL (2022) Circular RNAs: characterization, cellular roles, and applications. Cell 185(12):2016–2034PubMed

Long GV, Grob JJ, Nathan P et al (2016) Factors predictive of response, disease progression, and overall survival after dabrafenib and trametinib combination treatment: a pooled analysis of individual patient data from randomised trials. Lancet Oncol 17(12):1743–1754PubMed

Luke JJ, Flaherty KT, Ribas A et al (2017) Targeted agents and immunotherapies: optimizing outcomes in melanoma. Nat Rev Clin Oncol 14(8):463–482PubMed

Miranda KC, Huynh T, Tay Y et al (2006) A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell 126(6):1203–1217PubMed

O’Neill K, Liao WW, Patel A et al (2018) TEsmall identifies small RNAs associated with targeted inhibitor resistance in melanoma. Front Genet 9:461PubMedPubMedCentral

Peinado H, Aleckovic M, Lavotshkin S et al (2012) Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med 18(6):883–891PubMedPubMedCentral

Robert C, Grob JJ, Stroyakovskiy D et al (2019) Five-year outcomes with dabrafenib plus trametinib in metastatic melanoma. N Engl J Med 381(7):626–636PubMed

Shang Q, Du H, Wu X et al (2022) FMRP ligand circZNF609 destabilizes RAC1 mRNA to reduce metastasis in acral melanoma and cutaneous melanoma. J Exp Clin Cancer Res 41(1):170PubMedPubMedCentral

Shannon P, Markiel A, Ozier O et al (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13(11):2498–2504PubMedPubMedCentral

Singleton KR, Crawford L, Tsui E et al (2017) Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence. Cell Rep 21(10):2796–2812PubMedPubMedCentral

Song WM, Zhang B (2015) Multiscale embedded gene co-expression network analysis. PLoS Comput Biol 11(11):e1004574PubMedPubMedCentral

Sticht C, De La Torre C, Parveen A et al (2018) miRWalk: an online resource for prediction of microRNA binding sites. PLoS One 13(10):e0206239PubMedPubMedCentral

Su Y, Ko ME, Cheng H et al (2020) Multi-omic single-cell snapshots reveal multiple independent trajectories to drug tolerance in a melanoma cell line. Nat Commun 11(1):2345PubMedPubMedCentral

Tan Y, Tang F, Li J et al (2022) Tumor-derived exosomes: the emerging orchestrators in melanoma. Biomed Pharmacother 149:112832PubMed

Thery C, Zitvogel L, Amigorena S (2002) Exosomes: composition, biogenesis and function. Nat Rev Immunol 2(8):569–579PubMed

Valadi H, Ekstrom K, Bossios A et al (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9(6):654–659PubMed

Vellano CP, White MG, Andrews MC et al (2022) Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy. Nature 606(7915):797–803PubMedPubMedCentral

Wang XT, Xie YB, Xiao Q (2011) Lentivirus-mediated RNA interference targeting E2F–1 inhibits human gastric cancer MGC-803 cell growth in vivo. Exp Mol Med 43(11):638–645PubMedPubMedCentral

Wang TB, Geng M, Jin H et al (2021) SREBP1 site 1 protease inhibitor PF-429242 suppresses renal cell carcinoma cell growth. Cell Death Dis 12(8):717PubMedPubMedCentral

Webber J, Steadman R, Mason MD et al (2010) Cancer exosomes trigger fibroblast to myofibroblast differentiation. Cancer Res 70(23):9621–9630PubMed

Xia S, Feng J, Chen K et al (2018) CSCD: a database for cancer-specific circular RNAs. Nucleic Acids Res 46(D1):D925–D929PubMed

Xiao D, Barry S, Kmetz D et al (2016) Melanoma cell-derived exosomes promote epithelial-mesenchymal transition in primary melanocytes through paracrine/autocrine signaling in the tumor microenvironment. Cancer Lett 376(2):318–327PubMedPubMedCentral

Yu G, Wang LG, Han Y et al (2012) clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16(5):284–287PubMedPubMedCentral

Yu T, Liu K, Wu Y et al (2014) MicroRNA-9 inhibits the proliferation of oral squamous cell carcinoma cells by suppressing expression of CXCR4 via the Wnt/beta-catenin signaling pathway. Oncogene 33(42):5017–5027PubMed

Zhang H, Deng T, Liu R et al (2017) Exosome-delivered EGFR regulates liver microenvironment to promote gastric cancer liver metastasis. Nat Commun 8:15016PubMedPubMedCentral

Zhou PH, Zheng JB, Wei GB et al (2015) Lentivirus-mediated RASSF1A expression suppresses aggressive phenotypes of gastric cancer cells in vitro and in vivo. Gene Ther 22(10):793–801PubMedPubMedCentral

Titel: Suppression of exosomal hsa_circ_0001005 eliminates the Vemurafenib resistance of melanoma
verfasst von: Xicheng Wang
Qiong Cheng
Publikationsdatum: 04.01.2023
Verlag: Springer Berlin Heidelberg
Erschienen in: Journal of Cancer Research and Clinical Oncology / Ausgabe 9/2023
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI: https://doi.org/10.1007/s00432-022-04434-y

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Suppression of exosomal hsa_circ_0001005 eliminates the Vemurafenib resistance of melanoma

Abstract

Objectives

Methods

Results

Conclusions

Neu im Fachgebiet Onkologie

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

15% bedauern gewählte Blasenkrebs-Therapie

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Onkologie

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Objectives

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2023

Role of Fyn in hematological malignancies

Integration of transcriptomics and metabolomics reveals a novel gene signature guided by FN1 associated with immune response in oral squamous cell carcinoma tumorigenesis

Influence of neo-adjuvant radiotherapy on the intestinal microbiota of rectal cancer patients

Combined effects of vitamin D and neferine on the progression and metastasis of colorectal cancer

Anticancer acumens of three Annona species: a proportional review

The role of systemic inflammatory response index (SIRI) and tumor-infiltrating lymphocytes (TILs) in the prognosis of patients with laryngeal squamous cell carcinoma

Neu im Fachgebiet Onkologie

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

15% bedauern gewählte Blasenkrebs-Therapie

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Onkologie